Actively Recruiting
Estimation of Outcome and Quality of Life in ECMO Patients
Led by Heinrich-Heine University, Duesseldorf · Updated on 2024-05-06
1000
Participants Needed
1
Research Sites
261 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The availability as well as the use of extracorporeal membrane oxygenation (ECMO) systems for severe acute respiratory or cardiocirculatory failure is steadily increasing. The decision to initiate ECMO therapy is predominantly made in emergency situations, for which the focus is on acute survival. The decisions if a patient will profit from ECMO therapy are mainly made from clinical experience and educated guess by the attending team. However, it is unknown how useful these clinical predictions are. Therefore, this observational study will compare estimated and real outcome of ECMO patients.
CONDITIONS
Official Title
Estimation of Outcome and Quality of Life in ECMO Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Start of ECMO therapy within the past 24 hours
- Written informed consent from the patient or a health-care proxy
You will not qualify if you...
- Under 18 years of age
- Unable to communicate in German, the local language, or English
- Not receiving ECMO therapy or ECMO therapy lasting more than 24 hours
- No written consent given
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Hospital Duesseldorf
Düsseldorf, North Rhine-Westphalia, Germany, 40225
Actively Recruiting
Research Team
R
René M'Pembele, MD
CONTACT
S
Sebastian Roth, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here